-
Mashup Score: 0Large language models are getting bigger and better - 2 day(s) ago
Can they keep improving forever?
Source: www.economist.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1 - 2 day(s) ago
Key Points. Better clinical responses to teclistamab correlate with a more functional initial immune T-cell repertoire in the periphery and tumor siteMore
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma - 5 day(s) ago
Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA therapy exposure, albeit with slightly poorer progression-
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma - 16 day(s) ago
Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA therapy exposure, albeit with slightly poorer progression-
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy - 16 day(s) ago
Key Points. Multiple myeloma patients previously treated with T-cell redirection therapy have significantly low risk of developing CRS with teclistamabPati
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Yuval Noah Harari argues that AI has hacked the operating system of human civilisation - 18 day(s) ago
Storytelling computers will change the course of human history, says the historian and philosopher
Source: www.economist.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Daniel Kahneman was a master of teasing questions - 18 day(s) ago
How a psychologist transformed economics
Source: www.economist.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis - 18 day(s) ago
Blood Cancer Journal – Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
Large language models are getting bigger and better Can they keep improving forever? #LLM https://t.co/5s6crrtgls